Robyn M. EmanuelAmylou C. DueckHolly L. GeyerJean‐Jacques KiladjianStefanie SlotSonja ZweegmanPeter A.W. te BoekhorstSuzan CommandeurHarry C. SchoutenFederico Sackmann2026-03-222026-03-22201210.1200/jco.2012.42.3863https://doi.org/10.1200/jco.2012.42.3863https://andeanlibrary.org/handle/123456789/43024Citaciones: 441The MPN-SAF TSS is a concise, valid, and accurate assessment of MPN symptom burden with demonstrated clinical utility in the largest prospective MPN symptom study to date. This new prospective scoring method may be used to assess MPN symptom burden in both clinical practice and trial settings.enMedicineMyeloproliferative neoplasmInternal medicineQuality of life (healthcare)MyelofibrosisEssential thrombocythemiaPolycythemia veraPhysical therapyMyeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsarticle